[The biosynthesis of pyridinenucleotides of abnormal structure in tumors].
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001921:Brain / Q000201:enzymology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000633:toxicity; D006026:Glycoside Hydrolases / Q000494:pharmacology; D008099:Liver / Q000201:enzymology; D008861:Microsomes / Q000201:enzymology*; D009243:NAD; D009249:NADP; D009374:Neoplasms, Experimental / Q000201:enzymology*; D009584:Nitrogen / Q000032:analysis; D009711:Nucleotides / Q000096:biosynthesis*; D009928:Organ Specificity; D011725:Pyridines / Q000096:biosynthesis*; D051381:Rats; D013154:Spleen / Q000201:enzymology
D000963:Antimetabolites; D009711:Nucleotides; D011725:Pyridines; D009243:NAD; D009249:NADP; D003520:Cyclophosphamide; D006026:Glycoside Hydrolases; D009584:Nitrogen
Untersuchungen zur Biosynthese abnorm strukturierter Pyridinnucleotide in Tumoren.